Skybiotech Healthcare Limited (BOM:512036)
144.95
+5.10 (3.65%)
At close: Mar 6, 2026
Skybiotech Healthcare Statistics
Total Valuation
BOM:512036 has a market cap or net worth of INR 277.58 million. The enterprise value is 367.75 million.
| Market Cap | 277.58M |
| Enterprise Value | 367.75M |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:512036 has 1.92 million shares outstanding.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 92.01% |
| Owned by Institutions (%) | n/a |
| Float | 153,004 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.40 |
| EV / Sales | 5.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -17.48% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | -5.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.33% in the last 52 weeks. The beta is -1.69, so BOM:512036's price volatility has been lower than the market average.
| Beta (5Y) | -1.69 |
| 52-Week Price Change | -28.33% |
| 50-Day Moving Average | 157.61 |
| 200-Day Moving Average | 185.10 |
| Relative Strength Index (RSI) | 52.70 |
| Average Volume (20 Days) | 283 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:512036 had revenue of INR 62.56 million and -18.95 million in losses.
| Revenue | 62.56M |
| Gross Profit | 27.31M |
| Operating Income | -22.11M |
| Pretax Income | -19.97M |
| Net Income | -18.95M |
| EBITDA | -12.64M |
| EBIT | -22.11M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 43.66%, with operating and profit margins of -35.35% and -30.30%.
| Gross Margin | 43.66% |
| Operating Margin | -35.35% |
| Pretax Margin | -31.92% |
| Profit Margin | -30.30% |
| EBITDA Margin | -20.21% |
| EBIT Margin | -35.35% |
| FCF Margin | n/a |
Dividends & Yields
BOM:512036 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |